US 12275769
Activatable interleukin 12 polypeptides and methods of use thereof
granted A61KA61K2039/585A61K38/00
Quick answer
US patent 12275769 (Activatable interleukin 12 polypeptides and methods of use thereof) held by Werewolf Therapeutics, Inc. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Werewolf Therapeutics, Inc.
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/585, A61K38/00